Week in Review: March 6

The Week in Review provides an overview of the past week’s top health care content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news, and upcoming events.

weekinreview_in

1.1 Billion Young People at Risk of Losing Their Hearing, WHO Says

This just in from the World Health Organization: Your mother was right all along. About 1.1 billion people are at risk for losing their hearing, and half of 12- to 35-year-olds in high income countries expose their ears to "unsafe" sound levels when they listen to audio devices, the WHO announced today. And about 40 percent of them are exposed to "potentially damaging" sound levels at music and entertainment venues. Via ABC News.

Read article

A New Treatment for Migraines Is Showing Promising Results 

Treating migraines effectively might have gotten a lot easier, according to a new study published this month. Researchers at the Albany Medical Center claim that a new innovative treatment offers chronic migraine sufferers prolonged relief from the debilitating headaches. During the procedure, clinicians insert a spaghetti-size catheter through the patient’s nasal passages and administer lidocaine to the sphenopalatine ganglion — a nerve bundle behind the nose that is associated with migraines. It should be noted that no needles actually touch the patient during the process. Via TIME. 

Read article

Doctors, Patients Scramble Ahead of High Court Obamacare Decision

As the U.S. Supreme Court takes on a make-or-break Obamacare case this week, a growing number of U.S. patients and their doctors are already devising a Plan B in case they lose medical coverage. The Court's ruling, expected by late June, will determine whether millions of Americans will keep receiving federal subsidies to help them pay for private health insurance under President Barack Obama's healthcare law. Via Reuters.

Read article

Deadly Superbug-Related Scopes Sold Without FDA Approval

CNN has learned that the manufacturer of the endoscope involved in two superbug deaths at UCLA never obtained permission to sell the device, according to an official at the Food and Drug Administration. Olympus started selling its TJF-Q180V duodenoscope in 2010, but the FDA didn't notice until late 2013 or early 2014 that the company had never asked for clearance to put it on the market, according to Karen Riley, deputy director of strategy for the FDA's Office of External Affairs. Via CNN.

Read article

Heroin Overdose Deaths Are Skyrocketing In The U.S.

According to a study conducted by the Centers for Disease Control and Prevention, heroin overdose deaths are skyrocketing across the United States. Between 2010 and 2013 alone, the number of deaths nearly tripled. Just over 8,200 Americans died from heroin overdoses in 2013, averaging 23 a day. Via Forbes.

Read article

weekinreview_mc

Early Intervention Essential for Proper Lymphedema Management 

Moving early to diagnose and treat lymphedema after breast cancer treatment can reverse this side effect or prevent it from becoming more severe. Yet, a consistent way of defining lymphedema, measuring it, and identifying those most at risk remains elusive. While debate and research on these issues continue, clinicians should nevertheless make early education, assessment, and intervention a priority, urged Sarah McLaughlin, MD, during her presentation at a Miami Breast Cancer Symposium mini-symposium on Thursday. Via OncLive.

Read article

View From The Top: CEO Of The Mayo Clinic

U.S. News & World Report recently named the Mayo Clinic in Rochester, Minnesota, the number one hospital in the country this year, a first for the hospital. The Mayo Clinic is world famous for a model that pays doctors salaries instead of fees, to head off the possibility of physicians ordering unnecessary tests to pad their incomes. Physicians also work on teams for better communication, and to keep costs down. The Mayo Clinic has been center stage in the debate over the Affordable Care Act and “bending the curve” on the high cost of healthcare in the U.S. Here & Now’s Robin Young speaks with Dr. John Noseworthy, president and CEO of the Mayo Clinic, who says “it’s that team-based, patient-centeredness that drives us forward.” Via WBUR Here & Now.

Read article

Study: Many Women Unaware Breast Density is Linked to Breast Cancer

A new Mayo Clinic study shows many women are not aware of breast density's impact on their risk for breast cancer. The study was recently published in the Journal of Clinical Oncology. In the study, a survey was conducted among 2,311 women ages 40-74 across the country. About 65 percent responded. Via KTTC.

Read article

Surgery Patients Might Not Need Sedative Before Anesthesia 

"I was not surprised with these results," said Dr. J.P. Abenstein, president of the American Society of Anesthesiologists, who had no part in the study. "Lorazepam is a long-acting sedative lasting about 12 hours." When a sedative is called for, the most commonly used drug is midazolam, which is a short-acting sedative in the same class of drugs as lorazepam, said Abenstein, who is also an associate professor of anesthesiology at the Mayo Clinic in Rochester, Minn. Via HealthDay.

Read article

Mayo Clinic Named to Fortune’s “100 Best Companies to Work For” List 

Fortune magazine named Mayo Clinic to its list of the “100 Best Companies Magazine cover with male hands creating a heart with his hands with the words "Best Companies to Work For" on the cover.to Work For” in 2015. This is Mayo’s 12th consecutive year on the magazine’s annual compilation of companies that rate high with employees. The list ranks Mayo Clinic 73 overall among the top 100 companies. Via Mayo Clinic News Network.

Read article

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.